WHOLE MITOCHONDRIAL GENOME SEQUENCING

Whole Mitochondrial Genome Sequencing is an advanced molecular diagnostic test that analyzes the complete mitochondrial DNA (mtDNA) sequence to identify genetic variations and mutations associated with inherited mitochondrial disorders. Mitochondria are specialized structures within cells responsible for producing energy, and abnormalities in mitochondrial DNA can lead to a wide range of metabolic, neurological, muscular, cardiac, and multisystem disorders.

This comprehensive sequencing test evaluates the entire mitochondrial genome, enabling detection of pathogenic variants, deletions, insertions, and heteroplasmic mutations that may contribute to mitochondrial disease. Whole mitochondrial genome analysis provides valuable diagnostic information for patients with unexplained neurological symptoms, muscle weakness, developmental delays, metabolic disorders, hearing loss, vision problems, and family histories suggestive of mitochondrial inheritance.

Benefits of the Test

• Analyzes the complete mitochondrial DNA sequence.
• Detects pathogenic mitochondrial mutations and variants.
• Supports diagnosis of inherited mitochondrial disorders.
• Helps identify causes of unexplained neurological symptoms.
• Assists in genetic counseling and family risk assessment.
• Provides comprehensive molecular genetic evaluation.
• Supports personalized disease management strategies.
• Facilitates early diagnosis and clinical decision-making.

Why Doctors Recommend This Test

Doctors recommend Whole Mitochondrial Genome Sequencing for individuals with suspected mitochondrial disease, unexplained neuromuscular disorders, metabolic abnormalities, developmental delays, recurrent neurological symptoms, multisystem involvement, or a family history suggestive of mitochondrial inheritance. The test helps identify disease-causing mitochondrial DNA mutations and supports accurate diagnosis.

Preparation Before Test

• No fasting is generally required.
• A blood sample is commonly collected for analysis.
• Provide previous genetic testing reports if available.
• Share relevant clinical and family medical history.
• Inform the healthcare provider about ongoing treatments.
• Follow all sample collection instructions provided by the laboratory.

Normal Reporting Time

Most Whole Mitochondrial Genome Sequencing reports at Focus Diagnostics are initiated within 2–3 hours of sample receipt for accessioning, DNA extraction, and sequencing workflow preparation. Complete sequencing, bioinformatics analysis, variant interpretation, quality review, and report generation generally require several working days depending on laboratory protocols and case complexity.

Who Should Take This Test?

This test may be recommended for:

• Patients with suspected mitochondrial disorders.
• Individuals with unexplained muscle weakness.
• Patients with neurological or neurodegenerative symptoms.
• Individuals with inherited metabolic disorders.
• Patients with developmental delays.
• People with unexplained hearing or vision loss.
• Individuals with a family history of mitochondrial disease.
• Patients requiring advanced genetic evaluation.

Detailed Information

Mitochondrial DNA is inherited primarily from the mother and contains genes essential for cellular energy production. Mutations within mitochondrial DNA can impair normal energy generation, leading to mitochondrial diseases that affect organs with high energy requirements, including the brain, muscles, heart, liver, and eyes.

Whole Mitochondrial Genome Sequencing provides a comprehensive assessment of all mitochondrial genes rather than targeting selected mutations. This approach increases diagnostic yield and allows detection of rare, novel, or complex mitochondrial DNA variants that may be missed by limited mutation panels.

Mitochondrial disorders can present with diverse symptoms, including chronic fatigue, muscle weakness, exercise intolerance, seizures, developmental delay, hearing impairment, vision abnormalities, cardiomyopathy, endocrine dysfunction, and metabolic disturbances. Because symptoms often overlap with other medical conditions, molecular confirmation through mitochondrial genome sequencing is valuable for accurate diagnosis.

The test utilizes advanced next-generation sequencing technologies and sophisticated bioinformatics analysis to identify clinically significant mitochondrial DNA variants. Results are interpreted by experienced molecular genetics specialists and correlated with clinical findings, family history, and other diagnostic investigations.

Identification of mitochondrial DNA mutations can guide treatment planning, genetic counseling, reproductive risk assessment, family screening, and long-term disease management. Early diagnosis may help improve clinical monitoring and support timely medical interventions.

Results should always be interpreted in conjunction with clinical evaluation and specialist genetic consultation. Additional nuclear gene testing or metabolic studies may be recommended depending on the patient's presentation.

At Focus Diagnostics, Whole Mitochondrial Genome Sequencing is performed using advanced sequencing platforms, validated molecular workflows, comprehensive variant analysis pipelines, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful genetic diagnostic results.